CONMED Corporation
New York Stock ExchangeCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- CEO
- Patrick J. Beyer
- Full Time Employees
- 3,900
- Sector
- Healthcare
- Industry
- Medical - Devices
- Address
- 11311 Concept Boulevard Largo FL United States of America 33773-4908
- IPO Date
- Jul 23, 1987
- CIK
- 0000816956
- Website
- conmed.com
- Similar Companies
- Business
- CONMED Corporation (NYSE: CNMD) develops, manufactures, and markets surgical devices and supplies for use in minimally invasive procedures and orthopedics worldwide. The company offers a broad portfolio of products including powered instruments such as the Buffalo Filter and HiClear Oscillating Saw; orthopedic implants and biologics under brands like BioBrace and CrossFix; endoscopy devices including the DuraClip and OneSnip; general surgery instruments like the Repose Retractor System; and patient positioners such as the Plastech Gel products. CONMED operates through two primary segments—Orthopedic Surgery and General Surgery—serving hospitals, ambulatory surgery centers, and outpatient clinics primarily in the United States, Europe, and Asia-Pacific. Founded in 1970 and headquartered in Largo, Florida, the company maintains manufacturing facilities in the U.S., Mexico, and Poland. In recent developments, CONMED completed the acquisition of In2Bones Global, Inc. in March 2024, expanding its upper extremity orthopedic portfolio with innovative implants and instrumentation; launched the next-generation AirSeal iGS system in 2024 to enhance laparoscopic procedures; and reported strong revenue growth in its orthopedic segment during 2025, driven by strategic investments in sports medicine and trauma solutions.[web:previous]
Here's Why You Should Retain CONMED Stock in Your Portfolio Now
Why Is Conmed (CNMD) Down 3.1% Since Last Earnings Report?
Can CAH's Surging Other Growth Businesses Become Its Next Profit Engine?
CONMED Corporation Appoints Celine Martin and Jeff Mirviss to its Board of Directors
CONMED Corporation Appoints Celine Martin and Jeff Mirviss to its Board of Directors
Is the Options Market Predicting a Spike in CONMED Stock?
CONMED's Q1 Earnings and Revenues Beat, Organic Sales Outlook Up
CONMED Corporation (CNMD) Q1 2026 Earnings Call Transcript
Compared to Estimates, Conmed (CNMD) Q1 Earnings: A Look at Key Metrics
Conmed (CNMD) Q1 Earnings and Revenues Beat Estimates
CONMED Corporation Announces First Quarter 2026 Financial Results
A Look at Conmed Corp (CNMD) After 3.3% Gain -- GF Value $78.09 vs Price $39.73
Here's Why You Should Retain CONMED Stock in Your Portfolio Now
CONMED Corporation to Announce First Quarter 2026 Financial Results on April 29, 2026
CONMED Corporation (NYSE:CNMD) Given Consensus Recommendation of “Reduce” by Analysts
Here's Why You Should Retain CONMED Stock in Your Portfolio Now
Conmed (CNMD) Up 22.9% Since Last Earnings Report: Can It Continue?
Here's Why You Should Retain CONMED Stock in Your Portfolio for Now
CONMED Corporation (NYSE:CNMD) Receives Consensus Recommendation of “Reduce” from Analysts
CONMED Q4 Earnings Call Highlights